Lung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrier-Reference-Cited by-同舟云学术

Lung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrier

Published:2014-03 Issue: Volume:178 Page:8-17
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Suk Jung Soo,Kim Anthony J.,Trehan Kanika,Schneider Craig S.,Cebotaru Liudmila,Woodward Owen M.,Boylan Nicholas J.,Boyle Michael P.,Lai Samuel K.,Guggino William B.,Hanes Justin

Funder

National Institutes of Health

Cystic Fibrosis foundation

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference56 articles.

1. Clinical review: severe asthma;Papiris;Crit. Care,2002

2. Pulmonary complications of cystic fibrosis;Flume;Respir. Care,2009

3. Gene transfer to the lung: lessons learned from more than 2 decades of CF gene therapy;Griesenbach;Adv. Drug Deliv. Rev.,2009

4. Gene therapy prospects—intranasal delivery of therapeutic genes;Podolska;Adv. Clin. Exp. Med.,2012

5. Progress and prospects: prospects of repeated pulmonary administration of viral vectors;Sinn;Gene Ther.,2009

Cited by 166 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. pH modification of gel mobility shift improves polyplex selection In Vivo;Biochemical and Biophysical Research Communications;2024-12

2. The biomolecule corona mediates pulmonary delivery of nanomedicine;European Journal of Pharmaceutics and Biopharmaceutics;2024-09

3. Behavior of Self‐Disintegrating Microparticles at the Air/Mucus Interface;Advanced NanoBiomed Research;2024-04-11

4. Opportunities and Challenges for Inhalable Nanomedicine Formulations in Respiratory Diseases: A Review;International Journal of Nanomedicine;2024-02

5. DNA-Based Nanostructured Platforms as Drug Delivery Systems;Chem & Bio Engineering;2024-01-09